KANLAL

Welcome to the Brand page for “KANLAL”, which is offered here for Pharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the treatment of liposomal acid lipase (lal) deficiency;.

Its status is currently believed to be active. Its class is unavailable. “KANLAL” is believed to be currently owned by “SYNAGEVA BIOPHARMA CORP.”


Owner:
SYNAGEVA BIOPHARMA CORP.
Owner Details
Description:
Pharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the treatment of Liposomal Acid Lipase (LAL) deficiency;
Categories: PHARMACEUTICAL PREPARATIONS TREATMENT